Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non-biologic systemic therapies
dc.contributor.author | Mason, K. J. | |
dc.contributor.author | Burden, A. D. | |
dc.contributor.author | Barker, J. | |
dc.contributor.author | Lunt, M. | |
dc.contributor.author | Ali, H. | |
dc.contributor.author | Kleyn, C. E. | |
dc.contributor.author | McElhone, K. | |
dc.contributor.author | Soliman, M. M. | |
dc.contributor.author | Green, Adèle C | |
dc.contributor.author | Griffiths, C. E. M. | |
dc.contributor.author | Reynolds, N. J. | |
dc.contributor.author | Ormerod, A. D. | |
dc.date.accessioned | 2021-05-18T08:48:15Z | |
dc.date.available | 2021-05-18T08:48:15Z | |
dc.date.issued | 2021 | en |
dc.identifier.citation | Mason KJ, Burden AD, Barker JNWN, Lunt M, Ali H, Kleyn CE, et al. Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non‐biologic systemic therapies. J Eur Acad Dermatol Venereol. 2021 May 3 | en |
dc.identifier.pmid | 33866626 | en |
dc.identifier.doi | 10.1111/jdv.17282 | en |
dc.identifier.uri | http://hdl.handle.net/10541/624045 | |
dc.description.abstract | None | en |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1111/jdv.17282 | en |
dc.title | Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non-biologic systemic therapies | en |
dc.type | Other | en |
dc.contributor.department | Division of Musculoskeletal and Dermatological Sciences, NIHR Manchester Biomedical Research Centre, The University of Manchester, Manchester, U | en |
dc.identifier.journal | Journal of the European Academy of Dermatology and Venereology | en |
dc.description.note | en |